Redx Pharma is a clinical-stage biopharmaceutical company developing precision medicines targeting oncology and fibrotic diseases, with a pipeline of small molecule inhibitors of oncogenic and fibrotic pathways.
Endpoints News reports Redx Pharma is pursuing another reverse merger, this time with Skye Bioscience, as biotechs increasingly turn to alternative listing routes.